Evidence map›Paper›PMID 31569263›Full record

ArticleEuropean journal of dentistry2019

Morus alba Stem Extract Suppresses Matrix Metalloproteinases (MMP)-1, MMP-9, and Tissue Inhibitors of Metalloproteinase (TIMP)-1 Expression via Inhibition of IκBα Degradation Induced by Porphyromonas gingivalis LPS Signal in THP-1 Cells.

Ichaya Yiemwattana, Ruchadaporn Kaomongkolgit, Sodsi Wirojchanasak, Niratcha Chaisomboon

Open access · hybridAbstract read
In one paragraph

Article in European journal of dentistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Nutrients · 2022
    Article
  4. Anti-Inflammatory and Anti-Bacterial Potential of Mulberry Leaf Extract on Oral Microorganisms.International journal of environmental research and public health · 2022
    Article
  5. Pharmacological Activities forFoods (Basel, Switzerland) · 2021
    Review
  6. Toxicity as prime selection criterion among SARS-active herbal medications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ichaya YiemwattanaDepartment of Preventive Dentistry, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand.
Ruchadaporn KaomongkolgitDepartment of Oral Diagnosis, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand.
Sodsi WirojchanasakDepartment of Preventive Dentistry, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand.
Niratcha ChaisomboonResearch Laboratory, Faculty of Dentistry, Naresuan University, Phitsanulok, Thailand.
Naresuan University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this study is to evaluate the inhibitory effects of MATERIALS AND

methodsTHP-1 cells were treated with noncytotoxic concentrations of MSE combined with 1 µg/mL of STATISTICAL ANALYSIS: Comparisons in experiments were analyzed with analysis of variance followed by Tukey honestly significant difference comparison test.

resultsTwenty and 40 µg/mL of MSE significantly downregulated MMP-1 and MMP-9 genes and protein expression but upregulated the gene expression of TIMP-1 (

conclusionsThe present observations suggest that MSE exerted a positive effect on the regulatory mechanism between MMPs and TIMP, which is an important implication for the therapeutic potential of MSE in periodontitis.

Identifiers

PMID31569263
PMCPMC6777175
OpenAlexW2977659520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.